p38 inhibition attenuates the pro-inflammatory response to C-reactive protein by human peripheral blood mononuclear cells

Journal of Molecular and Cellular Cardiology

Volumn 37, Issue 6, 2004, Pages 1111-1114

  Lim, Moon Y ^a   Wang, Hui ^a   Kapoun, Ann M ^a   O'Connell, Maile ^a   O'Young, Gilbert ^a   Brauer, Heather Ann ^b   Luedtke, Gregory R ^a   Chakravarty, Sarvajit ^a   Dugar, Sundeep ^a   Schreiner, George S ^a   Protter, Andrew A ^a   Higgins, Linda S ^a  

^a SCIOS INC   (United States)

^b KENYON COLLEGE   (United States)

Author keywords

C reactive protein; Inflammation; Monocytes; p38; Vascular disease

Indexed keywords

C REACTIVE PROTEIN; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN E2; SD 282; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; ATTENUATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INFLAMMATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

C-REACTIVE PROTEIN; DOWN-REGULATION; HUMANS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; SYNAPTOPHYSIN;

EID: 9644258932     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2004.09.015     Document Type: Article

References (15)

1. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
2. P. Libby, and M. Aikawa Stabilization of atherosclerotic plaques: new mechanisms and clinical targets Nat. Med. 8 2002 1257 1262
3. G.J. Blake, and P.M. Ridker Inflammatory bio-markers and cardiovascular risk prediction J. Intern.Med. 252 2002 283 294
4. K. Yasojima, C. Schwab, E.G. McGeer, and P.L. McGeer Generation of C-reactive protein and complement components in atherosclerotic plaques Am. J. Pathol. 158 3 2001 1039 1051
5. S. Kumar, J. Boehm, and J.C. Lee p38 MAPKs: key signalling molecules as therapeutic targets for inflammatory diseases Nat. Rev. Drug. Discov. 2 9 2003 717 726
6. S.P. Ballou, and G. Lozanski Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein Cytokine 4 5 1992 361 368
7. J.E. Volanakis Human C-reactive protein: expression, structure, and function Mol. Immunol. 38 2001 189 197
8. A.M. Kapoun, F. Liang, G. O'Young, D.L. Damm, D. Quon, and R.T. White B-Type natriuretic peptide exerts broad functional opposition to transforming growth factor-(beta) in primary human cardiac fibroblasts Circ. Res. 94 4 2004 453 461
9. J. Cermak, N.S. Key, R.R. Bach, J. Balla, H.S. Jacob, and G.M. Vercellotti C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor Blood 15 82 1993 513 520
10. S.M. Saadeddin, M.A. Habbab, and G.A. Ferns Markers of inflammation and coronary artery disease Med. Sci. Monit. 8 2002 RA5 RA12
11. K.K. Hale, D. Trollinger, M. Rihanek, and C.L. Manthey Differential expression and activation of p38 MAPK α, β, γ and δ in inflammatory cell lineages J. Immunol. 162 1999 4246 4252
12. B. Ge, H. Gram, F. Di Padova, B. Huang, L. New, and R.J. Ulevitch MAPKK-independent activation of p38 mediated by TAB-1 dependent phosphorylation of p38, 2002 Science 295 2003 1291 1294
13. A.H. Moons, M. Levi, and R.J. Peters Tissue factor and coronary artery disease Cardiovasc. Res. 1 53 2002 313 325
14. H.D. Danenberg, A.J. Szalai, R.V. Swaminathan, L. Peng, Z. Chen, and P. Seifert Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice Circulation 108 5 2003 512 515
15. T. Khreiss, L. Jozsef, L.A. Potempa, and J.G. Filep Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells Circulation 109 16 2004 2016 2022